This site uses cookies to improve your experience and to provide services and advertising. By continuing to browse, you agree to the use of cookies described in our Cookies Policy. You may change your settings at any time but this may impact on the functionality of the site. To learn more see our Cookies Policy.
#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Dublin: 10 °C Sunday 7 June, 2020

This Irish company has produced the new 'gold standard' in medical technology

Aerogen’s drug nebulisers are being used in the intensive-care units of hospitals in 70 countries.

Aerogen CEO John Power
Aerogen CEO John Power

IRISH MEDICAL-TECHNOLOGY INNOVATORS Aerogen have developed the “gold standard” in delivering drugs to patients on ventilators in intensive-care units around the world.

The company, based in Dangan, Co Galway, makes nebulisers which allow medical staff to deliver drugs to a patient using an inhaler direct to where the medicine will be at its most effective.

“The emphasis, these days, is on getting the smallest amount of drug delivered to the correct location for a patient, in a targeted area,” Aerogen CEO and founder John Power told

Doctors want to get drugs into their lungs to treat these conditions. You don’t want to be injecting the drug into the vascular system, you want to get the drug into the lungs.”

About a decade after Aerogen first brought its product on to the market, Power said it was considered the “gold standard” for delivering drugs to patients who need ventilation to survive – from those on life support to premature babies in intensive care.

Its devices are an aid for the large share of hospital cases that deal with respiratory problems.

Put simply, its nebulisers converts drugs into an aerosol form, but they also include technology to control the particle size and delivery speed for the vapour.

They are capable of creating uniform droplets only 3.4 microns wide – about one-tenth the width of a human hair.

Solo Underside One of Aeorgen's nebulisers

Exporter of the year

The company was recently named Ireland’s exporter of the year at the Export Industry Awards in recognition of its reach into 70 countries and 30% growth each year since 2008.

It now makes 40 products and employs over 100 staff, a workforce set to expand further as it continues to expand in the big US healthcare market. The firm is currently looking for staff with experience marketing medical technology and product-development engineers.


Meanwhile, the next stage in its recent development will be adapting its technology for use in other environments like the emergency room and for home care.

Power said the biggest achievement in the early days of the business had been simply to survive without big domestic demand to support it.

“In the medical-technology market you really are a born global company. The Irish, internal market is so small you really need to export from day one and be ready to get up and move and travel.”

READ: Lung cancer deaths have increased in Ireland >

READ: This Dublin-designed probe is much smaller than a hair… and it could help cure cancer >

  • Share on Facebook
  • Email this article

About the author:

Peter Bodkin  / Editor, Fora

Read next: